Midkine (MK) is a retinoic acid-inducible heparin-binding cytokine. In the inflammatory synovitis of rheumatoid arthritis and osteoarthritis, MK was detected in synovial fluid, synoviocytes, and endothelial cells of new blood vessels. Normal synovial fluid and noninflammatory synovial tissue did not contain detectable MK. Therefore, MK showed inflammation-associated expression in these cases. Furthermore, MK was found to promote chemotaxis of neutrophils in the range of 10 ng/ml. The mode of action of MK was found to be hap to tactic; the substrate-bound form of MK was the active one. MK is also known to promote fibrinolysis. These activities of MK are in agreement with the modes of MK expression in various pathological statuses, and thus MK is proposed to be an important molecule regulating inflammatory responses.
Cytokines and growth factors are important in the control of inflammatory responses and tissue repair (1-4).
Although the roles of certain factors in these processes have become increasingly clear, we still do not have the entire picture of the cytokine/growth factor network responsible for their control. Herein, we present evidence that midkine (MK), a cytokine with multiple activities, plays important roles in these processes.
MK is a heparin-binding protein of 13 kDa, and was found as the product of a retinoic acid-responsive gene, which becomes activated at the early differentiation stage of embryonal carcinoma cells (5, 6) . MK is structurally unrelated to fibroblast growth factors, typical heparinbinding growth factors, and is the initial member of a new cytokine/growth factor family, which so far has only two members, MK and pleiotrophin (PTN, also called HB-GAM) (7) (8) (9) (10) (11) . MK enhances the survival, differentiation and neurite outgrowth of embryonic neurons and is mitogenic to certain cell lines (12) (13) (14) (15) . Since its discovery, MK has been implicated in the regulation of embryogenesis, based on the finding that it is expressed in various tissues in a manner strictly controlled both spatially and temporally during embryogenesis (16, 17) . In a healthy adult, MK is expressed only in highly restricted sites. Recently, it was found that an anti-MK antibody inhibits the differentiation of the tooth germ in vitro (18) .
On the other hand, the importance of MK in tissue repair and diseases has become increasingly clear. MK expression is increased in various human carcinomas, such as stomach, colon, pancreatic, lung, breast, and hepatocellular carcinomas (19) (20) (21) . High level expression of MK is correlated with a poor prognosis of patients with neuroblastomas (22) . The senile plaques in Alzheimer's disease invariably accumulate MK (23) . MK is newly expressed in the edematous region at an early stage of cerebral infarction (24) . These findings raised the possibility that MK is involved in tissue repair and abnormalities of the latter leading to diseases. Indeed, MK prevents retinal degeneration induced by prolonged exposure to light (25) . Recently, MK was found to enhance plasminogen activator activity in endothelial cells and to enhance fibrinolytic activity (26) , which is important in cell migration upon inflammation, tumor invasion and angiogenesis. These findings prompted us to examine MK expression in the inflammatory states associated with rheumatoid arthritis (RA) and osteoarthritis (OA). Furthermore, we examined whether MK triggers the initial stage of inflammation, namely, the recruitment of leukocytes (27) . Evidence obtained in this research combined with previous data enable us to propose that MK is one of the key molecules regulating the physiological and pathological processes of tissue inflammation.
MATERIALS AND METHODS
Human Synovial Fluid and Joint Biopsy SpecimensSynovial fluid was collected by aspiration from patients with inflamed synovitis accompanied by OA or RA. Synovial tissue was obtained upon total knee replacement for osteoarthritis and rheumatoid arthritis. The patients were 26-72 years of age, the average age being 52 years.
MK and Anti-MK Antibodies-Chemically synthesized human MK (28) was purchased from Peptide Research Institute, Mino, Osaka. Anti-human MK antibodies (29) and anti-mouse MK antibodies (14) were raised in rabbits and affinity purified as described in the respective references.
Assay for MK in Synovial Fluid-Enzyme-linked immunoassaying of MK was performed as described previously (29) .
Western Blotting-Samples were subjected to sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis as described by Laemmli (30) . Proteins in the gels were transferred to nitrocellulose membranes according to the method of Towbin et al. (31) . After incubation in 5% skim milk in Dulbecco's phosphate buffered saline (PBS) overnight at 4°C, the nitrocellulose sheets were incubated with diluted anti-human MK antibodies (20 //g/ml in 5% skim milk) for 2 h at room temperature. After washing with PBS containing 0.1% Tween 20, the membranes were incubated with affinity-purified anti-rabbit IgG conjugated with horseradish peroxidase (Jackson Immunoresearch Laboratories, Baltimore, USA), then stained with 4-chloro-lnaphthol.
Immunohistochemistry-Immunohistochemistry was performed as previously described (14) . Briefly, samples were fixed in neutralized buffered formalin and subsequently embedded in paraffin. The fixed samples were sliced at 5 /urn thickness. The sections were incubated overnight at 4°C with affinity-purified anti-human MK antibodies (15^g/ml, Ref. 29) in PBS containing 0.2% bovine serum albumin (BSA) and 2% normal goat serum. Control sections were incubated in either 2% BSA in PBS or normal rabbit serum. The sections were then incubated with biotinylated goat anti-rabbit antibodies (source dilution, 1:250 in PBS), then washed and incubated with avidin-biotin-peroxidase complex (Vector Laboratories, Burlingame, USA). Peroxidase was revealed by incubation with 3-amino-9-ethylcarbazole (AEC) containing 1% H 2 O 2 . In control staining, the first antibody (anti-human MK antibodies) was replaced with PBS containing 0.2% BSA and 2% normal goat serum. No staining was observed in control staining.
Assay of Efficacy of MK in Promoting Migration of Human Neutrophils-Human peripheral blood from healthy donors was fractioned by Ficoll-Hypaque density gradient centrifugation to isolate neutrophils (32) . After washing with RPMI1640 medium, the cells were suspended at a density of 2.5 X10 6 cells/ml in RPMI 1640 medium supplemented with 10% human serum from a blood group AB donor (AB serum). A typical preparation contained more than 95% viable neutrophils. The migration of neutrophils caused by MK was measured in a chemotaxicell (Kurabo, Osaka) as the upper chamber, which was identical to a Boyden chamber with an attached polycarbonate filter. As the lower chamber, a 24-well plate (3047, Falcon ) was used. MK was diluted in RPMI 1640 medium containing 10% AB serum, added to the 24-well plate, and then neutrophils (5 X 10 5 cells) in RPMI 1640 containing 10% AB serum were added to the chemotaxicell. The chambers were placed in a humidified incubator at 37°C with 5% CO 2 for 3h. Cells that migrated through the 5/am filter were fixed in 100% ethanol, stained, then counted. Counts were made in ten fields (Olympus AX80 microscope, magnification X 400) for each assay, and each sample was assayed in triplicate. Data were expressed as means±SEM. Checkerboard analysis was used to distinguish between chemotaxis (directed migration) and chemokinetics (random migration) (33) .
The haptotaxis assay was performed to determine whether MK functions in a soluble form (chemotactic mechanism) or a substrate-bound form (haptotactic mechanism) . The haptotaxis assay was conducted as described by Rot (34) . As the first step, positive haptotactic gradients of MK were established by filling some of the bottom wells with MK (1 to 100 ng/ml) to coat the lower surface of the membrane with MK, and the corresponding top wells were filled with RPMI 1640 medium. Negative haptotactic gradients were established by filling another set of top wells with MK (1 to 100 ng per well) and the corresponding bottom wells with RPMI 1640. To examine chemotaxis, both top and bottom wells were filled with RPMI 1640 medium. After incubation at 37°C for 20 min, the chemotaxicells, which consisted of the upper chamber and the polycarbonate filter were thoroughly washed in a RPMI medium bath to remove the attractant not bound to the filter. In the second step, RPMI medium containing 10% AB serum was used to fill the bottom wells corresponding to those wells with precoated positive and negative gradients. The wells corresponding to those that did not contain attractant in the first step were used to assess chemotaxis by adding attractants (1 to 100 ng/ml) to the bottom chambers. Neutrophils (5 X10 5 ) were placed in each top well of the second step, and their migration was measured by counting the cells that migrated across the filter during a 30 min incubation at 37°C. Counts were made in ten fields for each assay, and each sample was assayed in triplicate. All results were expressed as the number of neutrophils ±SEM. In patients with rheumatoid arthritis (RA) (n = 6), the values ranged from 62 to 10,000 pg/ml. In patients with osteoarthritis (OA) (n = 6), values ranged from non-detectable to 1,225 pg/ ml. In control synovial fluid from healthy human donors (n = 3), MK was not detectable. The limit of detection of MK in the present assay was 9 pg/ml. For convenience, the cases with non-detectable MK are plotted at the bottom of the figure.
RESULTS

MK Is Present in Synovial Fluid and Synovial Tissues
of Patients with Rheumatoid Arthritis and OsteoarthritisEnzyme immunoassay detected MK in synovial fluids of patients with RA and OA. The level of MK was 44 to 10,000 pg/ml. In the synovial fluid from three normal human subjects, MK was not detected. On the other hand, in all the six patients with RA, MK was present in synovial fluid (Fig.  1 ). In four of six patients with OA, the synovial fluid also contained significant amounts of MK (Fig. 1) . In two cases of OA, the synovial fluid was highly viscous, probably due to a high content of glycosaminoglycans, and MK was not detected before or after hyaluronidase digestion. Thus, we concluded that the presence of MK in synovial fluid is a phenomenon significantly related to the inflammatory status of synovitis. Biopsy specimens from five patients (three cases of RA and two of OA) were analyzed histochemically for the expression of MK. All the specimens comprised hyperplastic, inflamed synovial tissue, which was characterized histologically by the proliferation of synovial lining cells, extensive infiltration of lymphocytes and macrophages, and a number of new blood vessels. In the specimens from two RA patients, the area between synovial lining cells and new blood vessels was diffusely stained by an anti-MK antibody ( Fig. 2A) . Interestingly, synovial lining cells (Fig. 2B ) and endothelial cells of capillaries (Fig. 2C) were found to be intensely stained for MK. In one patient with RA , the staining was not as intense as in the other cases, probably because the disease was not in an active state. In two cases of an inflamed synovium with OA, the mode of immunostaining with the antibody to MK was almost the same as that in two patients with RA. Since a normal human synovium was not available for analysis, we examined biopsy specimens from a patient who had had an artificial joint replaced and who had no inflammatory synovitis; no immunostaining was detected in these specimens.
We also performed Western blot analysis of synovial tissue extracts. A high level of MK was detected in the extract from a case of active inflammatory synovitis with OA (Fig. 3, lane 1 ). An active inflammatory site of synovitis of RA contained a moderate level of MK (Fig. 3, lane 2) , while a lower level of MK was detected in an inactive inflammatory site in the same patient (Fig. 3, lane 3) . MK was not detected in the synovium from the patient with an artificial joint and no inflammatory synovitis (Fig. 3, lane  4) . Therefore, the MK immunoreactive material was confirmed to be MK. Furthermore, the tendency observed on immunohistochemistry, that the intensity of MK expression was correlated with the severity of the inflammation, was also observed on Western blot analysis.
MK Is a Chemotactic Factor Acting on Neutrophils-To evaluate the role of MK in the initial stage of the inflammatory reaction, namely, the recruitment of leukocytes, we examined the chemotactic activity of MK on neutrophils. On chamber analysis, MK placed in the lower chamber was found to stimulate the migration of neutrophils placed in the upper chamber (Fig. 4) . The optimum concentration of MK attracting neutrophils was lOng/ml (p<0.01) (Fig. 4) . Checkerboard analysis was performed to determine whether neutrophil migration in response to MK was directed (chemotactic) or random (chemokinetic) ( Table I) . Migration of neutrophils across the filter occurred whenever the concentration of MK in the lower chamber was greater than that in the upper chamber, indicating that migration occurred along a concentration gradient of MK, that is, MK was chemotactic rather than chemokinetic.
Given that cell motility is an adhesion-dependent event (27) , and MK strongly binds to syndecans (17, 35) , a family of cell surface heparansulfate proteoglycans (36), we also investigated the ability of substrate-bound MK to induce neutrophil migration. To examine MK-mediated neutrophil haptotaxis, MK was precoated on polycarbonate filters, and the filters were used as chemotaxis chambers in the absence of a soluble chemoattractant. MK bound to filters even at a low concentration (1 ng/ml) (p<0.01) stimulated neutrophil migration after only 30 min of incubation (•, Fig. 5 ). In the chemotaxis assay, stimulation of neutrophil migration was not detected with various concentrations of MK after 30 min of incubation (•, Fig. 5) . Stimulation of the migration was also not observed in a negative control, in which MK was absorbed to the same side of the filter as the target cells (O, Fig. 5 ).
DISCUSSION
In patients with inflammatory synovitis, namely, RA and OA, MK was found to be expressed in both synoviocytes and endothelial cells of adjacent blood vessels. This inflarn- mation-associated expression of MK was also reflected in the significant content of MK in the synovial fluid of the patients; normal synovial fluid did not contain detectable MK. This new expression of MK is likely to be involved in the etiology of synovitis, since we also found that MK is chemotactic toward neutrophils.
The migration of neutrophils into tissues involves interaction with the vascular endothelium and subsequent migration through the underlying basement membrane, during which time the neutrophils come into close contact with extracellular matrix components and connective tissue cells (27, 37) . The adherence of neutrophils to endothelial cells or extracellular matrices is likely to play a critical role in triggering neutrophil activation at extravascular sites of infection, inflammatory disorders, tissue damage, and remodeling.
Recently, chemoattractant factors belonging to a novel family of proinflammatory proteins were identified and classified as the chemokine family. These proteins play a key role in the orchestration of the immune response, ensuring that the correct immune effector cells are recruited and activated at the right place at the right time (38) (39) (40) (41) (42) . Typical members of the chemokine family are IL-8 (an a chemokine), which is chemoattractive to neutrophils, and macrophage inflammatory protein 1/J (MTP-1/3; a/3 chemokine), which is chemoattractive to monocytes. Recent structural studies revealed that while the monomeric structures of a and /3 chemokines are very similar, their dimeric structures are dramatically different from each other, suggesting that this structural difference may account for the functional differences between the two families (43) .
We could find no homology between MK and members of the chemokine family. However, both MK and chemokine family members have high contents of cysteine and basic amino acids. IL-8 is an 8-kDa protein and has three antiparallel y8-sheets (44) . MK is a 13-kDa protein and consists of two domains (45) , each of which has three anti-parallel P sheets (Inagaki, F., personal communication); a domain of MK exhibits overall similarity to IL-8 in the 3-D structure. In this respect, it is noteworthy that dimeric IL-8 is also active (43) : the dimeric form of IL-8 may well have a shape similar to that of the MK monomer.
The similarity of MK and IL-8 extends to heparin-binding activity. MK strongly binds to heparin, and also to syndecans, cell-surface heparansulfate proteoglycans (17, 35) . IL-8 also strongly binds to heparin (46) . This heparinbinding activity is important for the haptotaxis mechanism underlying the actions of both factors, as mentioned below. For the attraction of leukocytes, chemotaxis or haptotaxis can be considered (27) . In chemotaxis, cells move in the direction of increasing concentrations of a chemoattractant, which typically is a soluble molecule that can diffuse away from the site of its production, where its concentration is highest. An alternative mechanism to chemotaxis is haptotaxis. In haptotaxis, cells migrate to the region of highest adhesiveness. On a gradient of an adhesive ligand affixed to the surface of vascular endothelial cells or to an extracellular matrix, motile cells such as leukocytes in the peripheral bloodstream will tend to accumulate in the region of highest ligand density. While soluble cytokines would be rapidly washed away from their source by the blood flow, a more efficient system would involve the capture of secreted cytokines by receptors on endothelial cells, resulting in a high concentration of cytokines located on the endothelial cells, which would function as a chemoattractant for blood cells and would activate the migrated cells. Proteoglycans on endothelial cell surface are considered to mediate the immobilization of cytokines and growth factors, suggesting that proteoglycans play key roles in the mechanism of haptotaxis (47, 48).
As described above, MK resembles IL-8 in mediating chemoattraction toward neutrophils. Importantly, MK exhibits another activity related to an inflammatory response, namely, enhancement of fibrinolytic activity (24) . To the best of our knowledge, this is the first case of a molecule exhibiting both chemotactic activity toward leukocytes and enhancement of fibrinolytic activity. For example, fibroblast growth factors enhance fibrinolytic activity (49) but do not exhibit chemotactic activity toward leukocytes. Chemokines such as IL-8 have chemoattractant activity toward inflammatory cells, but they have not been reported to enhance fibrinolytic activity. The concerted action of the two activities is important in the initial stage of inflammation, and will also contribute to the initiation of the pathological status. For example, MK will cause leukocyte migration in two distinct steps: one is the attraction of leukocytes through a haptotactic mechanism, and the other the infiltration of leukocytes from the bloodstream to a tissue by virtue of degradation of the basement membrane through the enhancement of fibrinolytic activity. The dual activities of MK will explain the physiological and pathological significance of the expression of MK in early stages of tissue damage and inflammation.
Finally, the chemotactic activity of MK toward neutrophils will be a key to analyze the action mechanism of MK, since the response occurs as early as in 30 min, enabling the use of various signal transduction inhibitors to dissect MK-induced cellular response.
